2. Search Result
Search Result
Results for "

CEP20

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W286743
    Nε-(Carboxymethyl)-L-lysine
    1 Publications Verification

    CML; N6-(Carboxymethyl)-L-lysine; Nε-(1-Carboxymethyl)-L-lysine

    		 Polo-like Kinase (PLK) ERK NF-κB Cancer
    Nε-(Carboxymethyl)-L-lysine (CML) is an orally active advanced glycation end product. Nε-(Carboxymethyl)-L-lysine upregulates the expression of PLK1 and CEP20, and induces the activation of RAGE and ERK/NFκB. Nε-(Carboxymethyl)-L-lysine drives centrosome amplification. Nε-(Carboxymethyl)-L-lysine induces malignant transformation of hepatocytes and promotes the development of hepatocellular carcinoma. Nε-(Carboxymethyl)-L-lysine induces epithelial-mesenchymal transition in osteosarcoma cells and enhances their migration and invasion properties .
    Nε-(Carboxymethyl)-L-lysine
  • HY-RS02509
    CEP20 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    CEP20 Human Pre-designed siRNA Set A contains three designed siRNAs for CEP20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CEP20 Human Pre-designed siRNA Set A
    CEP20 Human Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: